Real Estate -
REIT - Healthcare Facilities - NYSE - US
$ 64.16
-2.06 %
$ 28.1 B
Market Cap
337.68
P/E
1. INTRINSIC VALUE
Balance Sheet
Ventas, Inc.
| Current Assets | 1.35 B |
| Cash & Short-Term Investments | 898 M |
| Receivables | 376 M |
| Other Current Assets | 78 M |
| Non-Current Assets | 24.8 B |
| Long-Term Investments | 0 |
| PP&E | 0 |
| Other Non-Current Assets | 24.8 B |
| Current Liabilities | 1.3 B |
| Accounts Payable | 1.15 B |
| Short-Term Debt | 6.4 M |
| Other Current Liabilities | 146 M |
| Non-Current Liabilities | 14.1 B |
| Long-Term Debt | 13.7 B |
| Other Non-Current Liabilities | 318 M |
EFFICIENCY
Earnings Waterfall
Ventas, Inc.
| Revenue | 4.92 B |
| Cost Of Revenue | 2.83 B |
| Gross Profit | 2.1 B |
| Operating Expenses | 2.1 B |
| Operating Income | 0 |
| Other Expenses | -88.4 M |
| Net Income | 88.4 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Ventas, Inc.
| Net Income | 88.4 M |
| Depreciation & Amortization | 1.28 B |
| Capital Expenditures | -604 M |
| Stock-Based Compensation | 31 M |
| Change in Working Capital | 43.8 M |
| Others | -163 M |
| Free Cash Flow | 726 M |
Wall Street Analysts Price Targets
Ventas, Inc.
Wall Street analysts predict an average 1-year price target for VTR of $61.5 , with forecasts ranging from
a
low of
$51 to a high of $75 .
VTR Lowest Price Target
Wall Street Target
51 USD
-20.51%
VTR Average Price Target
Wall Street Target
61.5 USD
-4.21%
VTR Highest Price Target
Wall Street Target
75 USD
16.90%
4. DIVIDEND
ANALYSIS
0.76%
DIVIDEND YIELD
0.48 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Ventas, Inc.
Sold
0-3 MONTHS
18.5 M USD 2
3-6 MONTHS
15.6 M USD 1
6-9 MONTHS
10 M USD 3
9-12 MONTHS
1.67 M USD 3
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Ventas Announces First Quarter 2025 Earnings Release Date and Conference Call
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) will issue its first quarter 2025 earnings release after the close of trading on the New York Stock Exchange on Wednesday, April 30, 2025. A conference call to discuss those earnings will be held on Thursday, May 1, 2025 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can be.
businesswire.com
- 2 weeks ago
Here's Why You Should Retain Ventas Stock in Your Portfolio Now
Rising healthcare expenditures and an aging population support VTR's senior housing operating portfolio despite competition and tenant concentration risks.
zacks.com
- 2 weeks ago
Cramer's Stop Trading: Ventas
Jim Cramer breaks down why he's keeping an eye on shares of Ventas.
youtube.com
- 2 weeks ago
Ventas (VTR) Up 2.2% Since Last Earnings Report: Can It Continue?
Ventas (VTR) reported earnings 30 days ago. What's next for the stock?
zacks.com
- 1 month ago
Key Reasons to Add Ventas Stock to Your Portfolio Right Now
VTR is set to gain from rising healthcare spending amid an aging population. Accretive investments in the research portfolio and solid balance sheet bode well.
zacks.com
- 1 month ago
Ventas Stock Gains 14.1% in Three Months: Will the Trend Last?
VTR is likely to gain from an aging population, rising healthcare expenses, favorable outpatient visit trends and accretive investments in its research portfolio.
zacks.com
- 1 month ago
Demographic Trends Shaping REIT Portfolio Construction
Demographic shifts, including an aging population and migration trends, are key drivers of REIT performance, influencing sector allocations and investment strategies. Chilton focuses on single-family rental (SFR) and healthcare REITs, with targeted exposure to multifamily REITs in coastal and Sun Belt markets. The aging population boosts demand for senior housing and medical outpatient buildings, benefiting REITs like Welltower, Ventas, and American Healthcare REIT.
seekingalpha.com
- 1 month ago
Ventas, Inc. (VTR) Presents at Citi 2025 Global Property CEO Conference (Transcript)
Ventas, Inc. (NYSE:VTR ) Citi 2025 Global Property CEO Conference March 4, 2025 1:30 PM ET Company Participants Debra Cafaro - Chief Executive Officer Justin Hutchens - Executive Vice President-Senior Housing & Chief Investment Officer Bob Probst - Executive Vice President & Chief Financial Officer Conference Call Participants Nick Joseph - Citi Michael Griffin - Citi Nick Joseph Welcome to Citi's 2025 Global Property CEO Conference. I'm Nick Joseph here with Michael Griffin with Citi Research.
seekingalpha.com
- 1 month ago
Ventas to Participate in Investor Meetings at Citi 2025 Global Property CEO Conference
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will make a presentation at the Citi 2025 Global Property CEO Conference (the “Citi Conference”) on March 4, 2025 at 1:30 p.m. Eastern Time. The webcast will be accessible on the Company's website at ir.ventasreit.com/events-and-presentations. Any Company written materials accompanying the presentation at the Citi Conference will be available on the Company's website on or about March.
businesswire.com
- 1 month ago
All You Need to Know About Ventas (VTR) Rating Upgrade to Buy
Ventas (VTR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zacks.com
- 1 month ago
Ventas, Inc. (VTR) Q4 2024 Earnings Call Transcript
Ventas, Inc. (NYSE:VTR ) Q4 2024 Earnings Conference Call February 13, 2025 10:00 AM ET Company Participants Bill Grant - SVP, IR Debra Cafaro - Chairman & CEO Justin Hutchens - EVP, Senior Housing & Chief Investment Officer Bob Probst - EVP & CFO Conference Call Participants Omotayo Okusanya - Deutsche Bank Nick Joseph - Citi John Kilichowski - Wells Fargo Juan Sanabria - BMO Capital Markets Vikram Malhotra - Mizuho Richard Anderson - Wedbush Michael Carroll - RBC Capital Markets Ronald Kamdem - Morgan Stanley John Pawlowski - Green Street Wes Golladay - Baird Austin Wurschmidt - KeyBanc Capital Markets Mike Mueller - JPMorgan Nick Yulico - Scotiabank Operator Thank you for standing by. My name is Gail, and I will be your conference operator today.
seekingalpha.com
- 2 months ago
Ventas Q4 FFO and Revenues Top Estimates, Same-Store Cash NOI Rises
VTR's Q4 results reflect higher same-store cash NOI due to SHOP same-store average occupancy growth.
zacks.com
- 2 months ago
8. Profile
Summary
Ventas, Inc. VTR
COUNTRY
US
INDUSTRY
REIT - Healthcare Facilities
MARKET CAP
$ 28.1 B
Dividend Yield
0.76%
Description
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Contact
353 North Clark Street, Chicago, IL, 60654
https://www.ventasreit.com
IPO
Date
May 5, 1997
Employees
498
Officers
Mr. T. Richard Riney J.D.
Senior Advisor
Mr. Brian K. Wood
Chief Tax Officer & Senior Vice President
Ms. Carey Shea Roberts J.D.
Executive Vice President, General Counsel, Corporate Secretary and Ethics & Compliance Officer
Mr. Christian N. Cummings
Senior Vice President of Asset Management - Seniors Housing
Ms. Bhavana Devulapally
Senior Vice President & Chief Information Officer
Mr. Robert F. Probst
Executive Vice President & Chief Financial Officer
Mr. Peter J. Bulgarelli
Executive Vice President of Outpatient Medical & Research
Mr. Gregory R. Liebbe
Senior Vice President, Chief Accounting Officer & Controller
Ms. Debra A. Cafaro
Chairman & Chief Executive Officer
Mr. J. Justin Hutchens
Executive Vice President of Senior Housing & Chief Investment Officer